FOLD
Amicus Therapeutics Inc
NASDAQ: FOLD · HEALTHCARE · BIOTECHNOLOGY
$14.49
+0.00% today
Updated 2026-04-27
Market cap
$4.55B
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$6 – $15
Volume
3.5M
Amicus Therapeutics Inc (FOLD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-33.89M | $15.19M | $-36.86M | $-43.37M | $-13.98M | $-49.42M | $-33.74M | $-45.79M | $-51.67M | $-100.14M | $-150.53M | $-215.49M | $-299.95M | $-250.42M | $-233.29M | $-202.49M | $-166.57M | $-69.09M | $-33.89M | $33.15M |
| Capital expenditures | $2.03M | $669000.00 | $2.67M | $1.81M | $384000.00 | $1.42M | $4.32M | $695000.00 | $238000.00 | $4.82M | $5.95M | $4.53M | $6.31M | $20.01M | $3.23M | $3.88M | $3.77M | $7.44M | $3.55M | $3.30M |
| Depreciation | $952452.00 | $1.24M | $1.49M | $2.13M | $2.06M | $1.58M | $1.71M | $1.72M | $1.55M | $1.83M | $3.24M | $3.59M | $4.22M | $4.78M | $8.85M | $6.21M | $5.34M | $7.87M | $8.55M | $2.57M |
| Stock-based comp | — | $2.82M | $6.45M | $7.79M | $6.19M | $8.68M | $6.19M | $6.18M | $6.01M | $9.97M | $17.50M | $23.10M | $29.26M | $44.43M | $49.15M | $57.84M | $76.51M | $86.08M | $84.91M | $87.41M |
| Free cash flow | $-35.92M | $14.52M | $-39.53M | $-45.18M | $-14.37M | $-50.84M | $-38.07M | $-46.49M | $-51.91M | $-104.96M | $-156.49M | $-220.01M | $-306.26M | $-270.43M | $-236.52M | $-206.38M | $-170.34M | $-76.53M | $-37.44M | $29.85M |
| Investing cash flow | $-26.60M | $-75.04M | $21.75M | $31.87M | $-19.44M | $46.45M | $-39.43M | $26.08M | $-107.08M | $-145.34M | $-4.51M | $-171.24M | $-121.20M | $95.15M | $-13.58M | $78.76M | $92.32M | $98.06M | $-560000.00 | $-46.43M |
| Financing cash flow | $66.17M | $91.91M | $-998000.00 | $2.77M | $43.66M | $-934000.00 | $81.48M | $29.38M | $139.18M | $290.89M | $272.71M | $247.43M | $450.77M | $217.50M | $262.86M | $212.07M | $-7.46M | $61.68M | $5.12M | $610000.00 |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $3.23M | $32.25M | $15.01M | $4.31M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-3.90M | $8.30M | $9.67M | $-19.57M | $45.41M | $117.54M | $-137.97M | $29.62M | $62.24M | $15.99M | $88.34M | $-81.72M | — | — | — |